Developing new chemical reactions to create medicines more efficiently
New Base-Promoted Oxidative and Reductive Coupling Reactions
['FUNDING_OTHER'] · COLORADO STATE UNIVERSITY · NIH-11081155
This study is exploring new ways to make important ingredients for medications, which could help create better and more effective treatments for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLORADO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (FORT COLLINS, UNITED STATES) |
| Trial ID | NIH-11081155 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative chemical reactions that can improve the synthesis of essential compounds for new medications. By introducing new methods that allow for the combination of two nucleophiles or electrophiles, the project aims to overcome existing limitations in organic synthesis. The approach utilizes common functional groups and novel oxidants to streamline the production of complex molecules, which are crucial for drug development. Patients may benefit from this research as it could lead to the discovery of new and more effective medications.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals in need of new therapeutic options for various medical conditions.
Not a fit: Patients with conditions that are not addressed by new medications developed through these synthetic methods may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could significantly enhance the availability of new medicines for patients.
How similar studies have performed: Other research has shown promise in developing new synthetic methods, indicating that this approach could lead to significant advancements in drug development.
Where this research is happening
FORT COLLINS, UNITED STATES
- COLORADO STATE UNIVERSITY — FORT COLLINS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BANDAR, JEFFREY S — COLORADO STATE UNIVERSITY
- Study coordinator: BANDAR, JEFFREY S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.